Return to search

Ensem Therapeutics nabs $67m

Ensem Therapeutics Inc, a Boston-based biotechnology company, has raised $67 million in funding.

Ensem Therapeutics Inc, a Boston-based biotechnology company, has raised $67 million in funding. The company’s backers include GGV Capital and Pavilion Capital.

Source: Press Release